Cargando…

Impact of exposure to malaria and nutritional status on responses to the experimental malaria vaccine ChAd63 MVA ME-TRAP in 5-17 month-old children in Burkina Faso

The experimental malaria vaccine ChAd63 MVA ME-TRAP previously showed protective efficacy against Plasmodium falciparum infection in Phase IIa sporozoite challenge studies in adults in the United Kingdom and in a Phase IIb field efficacy trial in Kenyan adults. However, it failed to demonstrate effi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morter, Richard, Tiono, Alfred B., Nébié, Issa, Hague, Oliver, Ouedraogo, Alphonse, Diarra, Amidou, Viebig, Nicola K., Hill, Adrian V. S., Ewer, Katie J., Sirima, Sodiomon B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755991/ https://www.ncbi.nlm.nih.gov/pubmed/36532031 http://dx.doi.org/10.3389/fimmu.2022.1058227

Ejemplares similares

Transplacental Transmission of Plasmodium falciparum in a Highly Malaria Endemic Area of Burkina Faso
por: Ouédraogo, Alphonse, et al.
Publicado: (2012)

Hospital-based surveillance of severe paediatric malaria in two malaria transmission ecological zones of Burkina Faso
por: Tiono, Alfred B., et al.
Publicado: (2023)

Seasonal performance of a malaria rapid diagnosis test at community health clinics in a malaria-hyperendemic region of Burkina Faso
por: Diarra, Amidou, et al.
Publicado: (2012)

Placental malaria and low birth weight in pregnant women living in a rural area of Burkina Faso following the use of three preventive treatment regimens
por: Tiono, Alfred B, et al.
Publicado: (2009)

Malariometric Indices in the Context of Seasonal Malaria Chemoprevention in Children Aged 1.5 to 12 Years during the Period of High Malaria Transmission in the Suburban Area of Banfora, Burkina Faso
por: Ouattara, San M., et al.
Publicado: (2023)

Antibodies to malaria vaccine candidates are associated with chloroquine or sulphadoxine/pyrimethamine treatment efficacy in children in an endemic area of Burkina Faso
por: Diarra, Amidou, et al.
Publicado: (2012)

Malaria Morbidity in High and Seasonal Malaria Transmission Area of Burkina Faso
por: Ouédraogo, Alphonse, et al.
Publicado: (2013)

First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children
por: Tiono, Alfred B., et al.
Publicado: (2018)

Malaria Incidence in Children in South-West Burkina Faso: Comparison of Active and Passive Case Detection Methods
por: Tiono, Alfred B., et al.
Publicado: (2014)

Plasmodium falciparum genotypes diversity in symptomatic malaria of children living in an urban and a rural setting in Burkina Faso
por: Soulama, Issiaka, et al.
Publicado: (2009)

Clinical Variation of Plasmodium falciparum eba-175, ama-1, and msp-3 Genotypes in Young Children Living in a Seasonally High Malaria Transmission Setting in Burkina Faso
por: Soulama, Issiaka, et al.
Publicado: (2015)

Haemoglobin variants and Plasmodium falciparum malaria in children under five years of age living in a high and seasonal malaria transmission area of Burkina Faso
por: Bougouma, Edith C, et al.
Publicado: (2012)

Antibody responses to P. falciparum blood stage antigens and incidence of clinical malaria in children living in endemic area in Burkina Faso
por: Cherif, Mariama K., et al.
Publicado: (2017)

Humoral immunogenicity of ChAd63_MVA ME-TRAP vaccination in African infants and children
por: Bowyer, Georgina, et al.
Publicado: (2014)

Risk factors for Plasmodium falciparum infection in pregnant women in Burkina Faso: a community-based cross-sectional survey
por: Yaro, Jean Baptiste, et al.
Publicado: (2021)

Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants
por: Afolabi, Muhammed O, et al.
Publicado: (2016)

Contribution of the Rapid LAMP-Based Diagnostic Test (RLDT) to the Evaluation of Enterotoxigenic Escherichia coli (ETEC) and Shigella in Childhood Diarrhea in the Peri-Urban Area of Ouagadougou, Burkina Faso
por: Héma, Alimatou, et al.
Publicado: (2023)

Intermittent Preventive Treatment of Malaria Provides Substantial Protection against Malaria in Children Already Protected by an Insecticide-Treated Bednet in Burkina Faso: A Randomised, Double-Blind, Placebo-Controlled Trial
por: Konaté, Amadou T., et al.
Publicado: (2011)

Different approaches for delivery of Intermittent Preventive Treatment (IPT) to pregnant women in Burkina Faso
por: Ouédraogo, Alphonse, et al.
Publicado: (2010)

Humoral and cell-mediated immunity to MSP3 peptides in adults immunized with MSP3 in malaria endemic area, Burkina Faso
por: NEBIE, I, et al.
Publicado: (2009)

An epidemiological study to assess Plasmodium falciparum parasite prevalence and malaria control measures in Burkina Faso and Senegal
por: Diallo, Aldiouma, et al.
Publicado: (2017)

Low Specificity of a Malaria Rapid Diagnostic Test During an Integrated Community Case Management Trial
por: Tiono, Alfred B., et al.
Publicado: (2013)

Immunogenicity of ChAd63 + MVA ME-TRAP in Senegalese adults
por: Mensah, Victorine, et al.
Publicado: (2014)

Haematological parameters, natural regulatory CD4 + CD25 + FOXP3+ T cells and γδ T cells among two sympatric ethnic groups having different susceptibility to malaria in Burkina Faso
por: Sanou, Guillaume S, et al.
Publicado: (2012)

A controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso
por: Tiono, Alfred B, et al.
Publicado: (2013)

Erratum to: Low Specificity of a Malaria Rapid Diagnostic Test During an Integrated Community Case Management Trial
por: Tiono, Alfred B., et al.
Publicado: (2013)

Lessons learned from the use of HRP-2 based rapid diagnostic test in community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso
por: Tiono, Alfred B, et al.
Publicado: (2014)

Variation in haematological parameters in children less than five years of age with asymptomatic Plasmodium infection: implication for malaria field studies
por: Gansane, Adama, et al.
Publicado: (2013)

Risk of Plasmodium falciparum infection in south-west Burkina Faso: potential impact of expanding eligibility for seasonal malaria chemoprevention
por: Yaro, Jean Baptiste, et al.
Publicado: (2022)

Safety and immunogenicity of co-administration of meningococcal type A and measles–rubella vaccines with typhoid conjugate vaccine in children aged 15–23 months in Burkina Faso
por: Sirima, Sodiomon B., et al.
Publicado: (2021)

Plasmodium falciparum Malaria in Children Aged 0-2 Years: The Role of Foetal Haemoglobin and Maternal Antibodies to Two Asexual Malaria Vaccine Candidates (MSP3 and GLURP)
por: Kangoye, David Tiga, et al.
Publicado: (2014)

Durable Anti-Vi IgG and IgA Antibody Responses in 15-Month-Old Children Vaccinated With Typhoid Conjugate Vaccine in Burkina Faso
por: Ouedraogo, Alphonse, et al.
Publicado: (2023)

Antibody levels against GLURP R2, MSP1 block 2 hybrid and AS202.11 and the risk of malaria in children living in hyperendemic (Burkina Faso) and hypo-endemic (Ghana) areas
por: Adu, Bright, et al.
Publicado: (2016)

Risk factors associated with house entry of malaria vectors in an area of Burkina Faso with high, persistent malaria transmission and high insecticide resistance
por: Yaro, Jean Baptiste, et al.
Publicado: (2021)

Implementation of Home based management of malaria in children reduces the work load for peripheral health facilities in a rural district of Burkina Faso
por: Tiono, Alfred B, et al.
Publicado: (2008)

Morbidity from Malaria in Children in the Year after They Had Received Intermittent Preventive Treatment of Malaria: A Randomised Trial
por: Konaté, Amadou T., et al.
Publicado: (2011)

In vitro antiplasmodial and cytotoxic properties of some medicinal plants from western Burkina Faso
por: Sanon, Souleymane, et al.
Publicado: (2013)

Feasibility of Malaria Diagnosis and Management in Burkina Faso, Nigeria, and Uganda: A Community-Based Observational Study
por: Ajayi, IkeOluwapo O., et al.
Publicado: (2016)

Malaria relevance and diagnosis in febrile Burkina Faso travellers: a prospective study
por: Schrot-Sanyan, Stéphanie, et al.
Publicado: (2013)

Safety and Immunogenicity of the Malaria Vaccine Candidate MSP3 Long Synthetic Peptide in 12–24 Months-Old Burkinabe Children
por: Sirima, Sodiomon B., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_qb0gnth7bg8vcgb9bvl62dr4so